What is BioInsights by Innovlabs.ai?
BioInsights is an AI-powered platform that helps biotech, pharma, and research teams analyze and visualize biological datasets. From genomics and proteomics to clinical and imaging data, publish-ready charts, AI-driven insights, and compliance-ready workflows
Problem
Biotech, pharma, and research teams manually analyze diverse biological datasets (genomics, proteomics, clinical, imaging) using disconnected tools, leading to time-consuming processes, inefficient visualization, and compliance challenges.
Solution
An AI-powered analytics platform enabling users to automatically analyze multi-modal biological data, generate publish-ready visualizations, and streamline compliance-ready workflows for faster drug discovery.
Customers
Biotech researchers, pharmaceutical R&D teams, and academic lab scientists requiring rapid, compliant data insights for pre-clinical studies.
Unique Features
Unified AI/ML pipeline for genomics, proteomics, imaging, and clinical data; automated FDA/ISO-compliant audit trails; one-click publication-quality charts.
Traction
Launched on ProductHunt (https://www.producthunt.com/products/bioinsights-by-innovlabs-ai) with 100+ upvotes; partnered with 5+ mid-tier biopharma companies; undisclosed revenue but comparable AI drug discovery tools average $20k-$50k/month per enterprise.
Market Size
The global AI in drug discovery market was valued at $1.1 billion in 2023 and is projected to reach $4.9 billion by 2028 (CAGR 34.7%).
